Cargando…
076 Risk of severe COVID-19 associated with immune-modifying drugs: data from PsoProtect and Global Rheumatology Alliance registries
Autores principales: | Group, P Study, Alliance Study Group, G. Rheumatology |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672429/ http://dx.doi.org/10.1016/j.jid.2022.09.086 |
Ejemplares similares
-
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
por: Machado, Pedro M, et al.
Publicado: (2023) -
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
por: Heart Protection Study Collaborative Group
Publicado: (2011) -
Initial data from the COVID-19 Global Rheumatology Alliance provider registries
por: Vanjak, Anthony
Publicado: (2020) -
Ctf2 design report: The CLIC Test Facility - CTF2 A two-beam test accelerator for linear collider studies The CLIC Study Group
por: CLIC Study Group
Publicado: (1996) -
Meeting held at Saclay, 30-31 May 1961 : notes
por: European Accelerator Study Group
Publicado: (1961)